Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1

Status

Completed 8Active not recruiting 5Terminated 3Recruiting 3

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Conditions

Breast Neoplasms 993Neoplasms 852Carcinoma, Non-Small-Cell Lung 845Prostatic Neoplasms 528Neoplasm Metastasis 501Leukemia, Myeloid, Acute 489Melanoma 456Colorectal Neoplasms 447Multiple Myeloma 441Lung Neoplasms 422Pancreatic Neoplasms 353Recurrence 350Lymphoma 350Ovarian Neoplasms 341Lymphoma, Non-Hodgkin 329Leukemia 324Leukemia, Lymphocytic, Chronic, B-Cell 302Precursor Cell Lymphoblastic Leukemia-Lymphoma 271Carcinoma, Renal Cell 256Head and Neck Neoplasms 246Brain Neoplasms 245Carcinoma, Hepatocellular 234Glioblastoma 232Squamous Cell Carcinoma of Head and Neck 231Myelodysplastic Syndromes 231Lymphoma, Large B-Cell, Diffuse 228Lymphoma, Follicular 219Colonic Neoplasms 191Stomach Neoplasms 182Rectal Neoplasms 175

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Interventional × Giant Cell Tumor of Tendon Sheath × Clear all
NCT04938180 2024-05-24

A Phase 2 Study of Intravenous AMB-05X in Tenosynovial Giant Cell Tumor Patients

AmMax Bio, Inc.

Phase 2 Terminated
4 enrolled 17 charts

Giant Cell Tumor of Tendon Sheath, Synovitis, Pigmented Villonodular

NCT01804530 2018-08-02

Phase 1 Study of PLX7486 as Single Agent in Patients With Advanced Solid Tumors

Plexxikon

Phase 1 Terminated
59 enrolled

Giant Cell Tumor of Tendon Sheath

NCT02673736 2018-08-02

A Study of PLX73086 in Advanced Solid Tumors and Locally Advanced or Refractory Tenosynovial Giant Cell Tumor

Plexxikon

Phase 1 Terminated
11 enrolled

Giant Cell Tumor of Tendon Sheath, Joint Diseases, Neoplasms, Synovitis, Synovitis, Pigmented Villonodular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡